Drugs / NY-ESO-1 ISCOMATRIX®
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00199901 Comparator | Sep 2005 → Dec 2008 | melanoma | Ludwig Institute for Cancer Research | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NY-ESO-1 ISCOMATRIX | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00199901 ↗ |
| Modality | Vaccine | “NY-ESO-1 ISCOMATRIX® vaccine” NCT00199901 ↗ |